What does Dr. Caroline Hoogmartens do?

Dr. Caroline Hoogmartens is a specialist medical practice in Brugge. Private Limited, started on 7 May 2021, 1 establishment.

What is the address of Dr. Caroline Hoogmartens?

The registered office of Dr. Caroline Hoogmartens is located at Kooidreef 3A, 8200 Brugge.

Is Dr. Caroline Hoogmartens still active?

Yes. According to the CBE (3 October 2026) Dr. Caroline Hoogmartens is active, legal situation “Normale toestand”, started on 7 May 2021.

Is Dr. Caroline Hoogmartens registered on Peppol?

Yes, Dr. Caroline Hoogmartens is registered on the Peppol network with ID 0208:0767986711.

What is the enterprise number of Dr. Caroline Hoogmartens?

The enterprise number of Dr. Caroline Hoogmartens is BE0767986711.

When was Dr. Caroline Hoogmartens founded?

Dr. Caroline Hoogmartens was founded on 7 May 2021.

Who are the directors of Dr. Caroline Hoogmartens?

According to the 2025 annual accounts, the directors of Dr. Caroline Hoogmartens are: Caroline Hoogmartens.

Is Dr. Caroline Hoogmartens a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 May 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Caroline Hoogmartens make in 2025?

Dr. Caroline Hoogmartens posted a profit after taxes of € 414,435 in financial year 2025.

What is the revenue of Dr. Caroline Hoogmartens?

As a small company, Dr. Caroline Hoogmartens is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 562,399.

Dr. Caroline Hoogmartens (Private Limited) - Brugge

Dossier Dr. Caroline Hoogmartens, printed on 3 October 2026 from databakkes.be/en/0767986711/dr-caroline-hoogmartens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Caroline Hoogmartens from Brugge, company number BE0767986711, closed financial year 2025 with a result of € 414,435 after tax. For that financial year Dr. Caroline Hoogmartens recorded a gross margin of € 562,399 and equity of € 1,000. Compared with financial year 2024, the result moved from € 284,000 to € 414,435. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Shrank hard

€ 1,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 414,435

▲ 46% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 161,656

▲ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 548,435 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 41,506

▲ € 37,358 vs 2024

Of which on lease € 38,557.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 38,099

€ 8,022 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 3,459

▼ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 16,708

▲ 228% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 59,300 Gross margin 2022: € 59,300 First fiscal year in the series	€ 237,368 Gross margin 2023: € 237,368 ▲ 300% vs 2022 (€ 59,300) Favourable step	€ 371,502 Gross margin 2024: € 371,502 ▲ 57% vs 2023 (€ 237,368) Favourable step	€ 562,399 Gross margin 2025: € 562,399 ▲ 51% vs 2024 (€ 371,502) Favourable step	▲ 51%
Profit after taxes	€ 46,893 Profit after taxes 2022: € 46,893 First fiscal year in the series	€ 181,359 Profit after taxes 2023: € 181,359 ▲ 287% vs 2022 (€ 46,893) Favourable step	€ 284,000 Profit after taxes 2024: € 284,000 ▲ 57% vs 2023 (€ 181,359) Favourable step	€ 414,435 Profit after taxes 2025: € 414,435 ▲ 46% vs 2024 (€ 284,000) Favourable step	▲ 46%
Equity	€ 42,531 Equity 2022: € 42,531 First fiscal year in the series	€ 188,890 Equity 2023: € 188,890 ▲ € 146,359 vs 2022 (€ 42,531) Favourable step	€ 135,000 Equity 2024: € 135,000 ▼ 29% vs 2023 (€ 188,890) Unfavourable step	€ 1,000 Equity 2025: € 1,000 ▼ 99% vs 2024 (€ 135,000) Unfavourable step	▼ 99%
Total debts	€ 41,393 Total debts 2022: € 41,393 First fiscal year in the series	€ 37,934 Total debts 2023: € 37,934 ▼ 8% vs 2022 (€ 41,393) Favourable step	€ 274,107 Total debts 2024: € 274,107 ▲ € 236,173 vs 2023 (€ 37,934) Unfavourable step	€ 590,682 Total debts 2025: € 590,682 ▲ 115% vs 2024 (€ 274,107) Unfavourable step	▲ 115%
Cash	€ 45,536 Cash 2022: € 45,536 First fiscal year in the series	€ 47,714 Cash 2023: € 47,714 ▲ 5% vs 2022 (€ 45,536) Favourable step	€ 95,608 Cash 2024: € 95,608 ▲ 100% vs 2023 (€ 47,714) Favourable step	€ 161,656 Cash 2025: € 161,656 ▲ 69% vs 2024 (€ 95,608) Favourable step	▲ 69%
Retained profit	€ 41,531 Retained profit 2022: € 41,531 First fiscal year in the series	€ 187,890 Retained profit 2023: € 187,890 ▲ € 146,359 vs 2022 (€ 41,531) Favourable step	€ 134,000 Retained profit 2024: € 134,000 ▼ 29% vs 2023 (€ 187,890) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 134,000) Unfavourable step	▼ 100%
Dividend	€ 15,000 Dividend 2022: € 15,000 First fiscal year in the series	€ 35,000 Dividend 2023: € 35,000 ▲ 133% vs 2022 (€ 15,000) Unchanged	€ 337,890 Dividend 2024: € 337,890 ▲ € 302,890 vs 2023 (€ 35,000) Unchanged	€ 548,435 Dividend 2025: € 548,435 ▲ 62% vs 2024 (€ 337,890) Unchanged	▲ 62%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 38,099 Bank debt 2025: € 38,099 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 83,924 Balance sheet total 2022: € 83,924 First fiscal year in the series	€ 226,824 Balance sheet total 2023: € 226,824 ▲ 170% vs 2022 (€ 83,924) Unchanged	€ 409,108 Balance sheet total 2024: € 409,108 ▲ 80% vs 2023 (€ 226,824) Unchanged	€ 591,682 Balance sheet total 2025: € 591,682 ▲ 45% vs 2024 (€ 409,108) Unchanged	▲ 45%

Key figures of Dr. Caroline Hoogmartens, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Caroline Hoogmartens?

What happened at Dr. Caroline Hoogmartens in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 414,435 (▲ 46% vs 2024). Source: NBB ↗
May 7, 2021 New establishment in Brugge. KBO
May 7, 2021 Start of the company according to the CBE. KBO

In short

From € 46,893 profit in 2022 to € 414,435 profit in 2025.

Paid € 297,502 in corporate taxes since 2022.

Best year ever: 2025, with € 414,435 profit.

Paid out € 936,326 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Caroline Hoogmartens? We notify you, reason included.

Follow Dr. Caroline Hoogmartens

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Caroline Hoogmartens

Dr. Caroline Hoogmartens

Behind Dr. Caroline Hoogmartens is Caroline Hoogmartens.

See the full network in the app

Directors

According to the 2025 annual accounts

Caroline Hoogmartens

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kooidreef 3A

8200 Brugge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CAVICA

€ 96,268 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0767.986.711
VAT number: BE 0767.986.711
Registered office: Kooidreef 3A, 8200 Brugge
Names & denominations: Dr. Caroline Hoogmartens
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 May 2021
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗